Millions of people are taking cholesterol-lowering drugs known as statins to lower their cholesterol. It’s a 29 billion dollar industry that had most of us fooled completely. Doctors prescribe these statin drugs regularly against heart attack, stroke, inflammation and other health ailments. However, despite their incredible popularity, cholesterol lowering drugs failed to prevent heart attack and stroke. Instead, they can cause cancer and other serious health problems.
In the new documentary film $29 Billion Reasons to Lie About Cholesterol, Justin Smith states,
” … between 1994 and 2006 the percentage of men aged 65 to 74 with ‘high’ cholesterol decreased from 87% to 54% … Despite this, the rate of coronary heart disease for this age group stayed about the same … Other age groups have experienced an increase in the rate of heart disease as the number of people with ‘high’ cholesterol has decreased.”
1Cholesterol-lowering drugs cause cancer.
Well-designed studies have shown the link between cholesterol-lowering drug use and cancer.
In the Journal of the American Medical Association in 1996 stated:
All members of the two most popular classes of lipid-lowering drugs (the fibrates and the statins) cause cancer in rodents, in some cases at levels of animal exposure close to those prescribed to humans. … Longer-term clinical trials and careful postmarketing surveillance during the next several decades are needed to determine whether cholesterol-lowering drugs cause cancer in humans. In the meantime, the results of experiments in animals and humans suggest that lipid-lowering drug treatment, especially with the fibrates and statins, should be avoided except in patients at high short-term risk of coronary heart disease.
Additionally, according to a 2011 study published in the journal Prostate, men who take statin drugs of any kind are significantly more prone to developing prostate cancer compared to other men. Compared to men who have never taken a statin drug, statin users were found to have a much as an 86 percent increased risk of developing prostate cancer.